Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension.
Rogério de SouzaMarion DelcroixNazzareno GaliéPavel JansaSanjay MehtaTomás PulidoLewis RubinB K S SastryGérald SimonneauOlivier SitbonAdam TorbickiNeli BoyanovaLiliya ChamitavaClaudia SteinRichard N ChannickPublished in: Advances in therapy (2022)
ClinicalTrials.gov Identifiers: NCT00660179 and NCT00667823.